Nuclear factor-kappa B signaling in skeletal muscle atrophy. - Wikidata - wikimedia - TriplyDB

Nuclear factor-kappa B signaling in skeletal muscle atrophy.

Nuclear factor-kappa B signaling in skeletal muscle atrophy.

http://www.wikidata.org/entity/Q34593476

about

Does skeletal muscle have an 'epi'-memory? The role of epigenetics in nutritional programming, metabolic disease, aging and exercise Inflammation and nutrition in children with chronic kidney disease Respiratory and limb muscle dysfunction in pulmonary arterial hypertension: a role for exercise training?The quasi-parallel lives of satellite cells and atrophying muscle Pharmacology of manipulating lean body mass The mechanisms of cachexia underlying muscle dysfunction in COPD The TWEAK-Fn14 pathway: a potent regulator of skeletal muscle biology in health and disease 2-Benzamido-N-(1H-benzo[d]imidazol-2-yl)thiazole-4-carboxamide derivatives as potent inhibitors of CK1δ/ε Insights into the molecular etiology of exercise-induced inflammation: opportunities for optimizing performance Molecular pathways leading to loss of skeletal muscle mass in cancer cachexia--can findings from animal models be translated to humans?Omega-3 Fatty Acids and Skeletal Muscle Health Tumor necrosis factor-α regulates distinct molecular pathways and gene networks in cultured skeletal muscle cells Regulatory circuitry of TWEAK-Fn14 system and PGC-1α in skeletal muscle atrophy program.Functional KCa1.1 channels are crucial for regulating the proliferation, migration and differentiation of human primary skeletal myoblasts METTL21C is a potential pleiotropic gene for osteoporosis and sarcopenia acting through the modulation of the NF-κB signaling pathway.Genomic profiling of messenger RNAs and microRNAs reveals potential mechanisms of TWEAK-induced skeletal muscle wasting in mice A Novel NF-κB Inhibitor, Edasalonexent (CAT-1004), in Development as a Disease-Modifying Treatment for Patients With Duchenne Muscular Dystrophy: Phase 1 Safety, Pharmacokinetics, and Pharmacodynamics in Adult Subjects Transforming growth factor-beta-activated kinase 1 is an essential regulator of myogenic differentiation.Grape seed extract prevents skeletal muscle wasting in interleukin 10 knockout mice Therapeutic targeting of signaling pathways in muscular dystrophy.The TWEAK-Fn14 dyad is involved in age-associated pathological changes in skeletal muscle The TWEAK-Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice.Dlk1 is necessary for proper skeletal muscle development and regeneration.Systems analysis of biological networks in skeletal muscle function.Enhanced transforming growth factor-beta signaling and fibrogenesis in ovine fetal skeletal muscle of obese dams at late gestation.Effects of age and sedentary lifestyle on skeletal muscle NF-kappaB signaling in men TWEAK causes myotube atrophy through coordinated activation of ubiquitin-proteasome system, autophagy, and caspases.PGC-1α induces mitochondrial and myokine transcriptional programs and lipid droplet and glycogen accumulation in cultured human skeletal muscle cells.Genetic ablation of TWEAK augments regeneration and post-injury growth of skeletal muscle in mice.Delayed recovery of skeletal muscle mass following hindlimb immobilization in mTOR heterozygous mice.Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice.Autophagy and skeletal muscles in sepsis Matrix metalloproteinase-9 inhibition improves proliferation and engraftment of myogenic cells in dystrophic muscle of mdx mice Potential role of nuclear factor κB in diabetic cardiomyopathy.Gene expression changes controlling distinct adaptations in the heart and skeletal muscle of a hibernating mammal Life or death by NFκB, Losartan promotes survival in dy2J/dy2J mouse of MDC1A.Hypothalamic inflammation: a double-edged sword to nutritional diseases.Muscle inflammation susceptibility: a prognostic index of recovery potential after hip arthroplasty?Attenuation of cellular toxicity by calpain inhibitor induced by bacterial endotoxin: a mechanistic study using muscle precursor cells as a model system.The TWEAK-Fn14 system: breaking the silence of cytokine-induced skeletal muscle wasting.

P2860

Q26751199-E752ADDD-C0D2-4663-AE54-9B31C712B918 Q26751530-DF72DFA4-5866-46E6-9FA8-4092C985299A Q26781677-222BB15F-251F-4966-A8E2-DE9E365DB8A5 Q26800207-C93AABA6-C524-407A-AD44-AF242F9436E5 Q26824503-F4C3B721-1430-4CF1-B46B-8DBBAD43E656 Q26828616-B30FF9F5-1B1C-47D2-902A-B302281A4289 Q26999255-B4616303-8C1D-4533-85F1-8C73EFBC255A Q27677250-C240E765-2B8D-49DD-B154-33DB58258D23 Q28066359-C4F8B2F8-6A49-44F1-9E7B-326B20D560D5 Q28068034-DF98ECB6-E959-44DA-BB72-256B2F539AEC Q28084892-B445058D-D0E5-4BFB-86FB-B4532E2DB214 Q28475735-5EED48E5-0CFB-48E2-BCE0-0B219229B149 Q28658848-07B8E78A-6653-4310-A9F4-3BB56F9A9DEE Q30830556-A6FB5723-9002-4C95-8F9D-35DD82225ED9 Q30973924-5E8B947E-A641-4C60-8983-3C5628F943DE Q33526358-0A569E53-A7FE-4595-AB0D-C8F1EE02983B Q33625958-9B34E4A4-ACF5-4744-966A-4BC4A8AA274E Q33673668-2A45C9A0-310F-4B94-B1A3-1B5BFBCB132B Q33696637-DC356C11-F49D-4086-A3BB-B04253B094CD Q33707964-4F304206-AB9C-43EF-B719-683B6019D05C Q33724956-B59DDD52-BFB7-44A3-B8CB-007F49A964F2 Q33751732-BD8C2C44-C9B4-4EAB-A47F-11EF66149346 Q33760580-7F78339B-E0F0-4326-8207-E0FC7503FF35 Q33828179-1F32E25E-86BC-4CE5-AC9B-0E12471817B4 Q33916545-FA238B23-BAE9-4F51-9D9C-347AB9A276BB Q33997272-6F383C23-A9AE-4098-90CE-1F13A2075A08 Q34132291-5AD48008-A122-4E99-8098-F284501F115D Q34137440-F176B707-92A0-429E-A7A6-22E3A22E7754 Q34162346-E617E414-4026-42F9-A8EB-FA3F03036E5F Q34321178-EEFE7A74-0631-41BB-8B7E-1E807EDD0819 Q34439637-72BE572A-AEAC-4A8E-ABB2-517F2EB938A9 Q34442945-21C54EFC-BDF2-4BEB-813E-CDCF783F14DA Q34973330-C6D3F2B6-7992-4E26-9C26-1A6799071ADD Q35104570-669D15CA-8D58-4065-8067-F23317388ADD Q35138466-CB549893-F221-461A-9ED7-730A2F6801A4 Q35274694-B3584857-E428-4436-B4EB-B473C52ED256 Q35318592-C8D4DD85-9BBB-42FD-A59D-D08F1BF47602 Q35436852-ABAE9CA3-8DC0-4EAC-8EC5-BBF49F5B724F Q35587987-56FC5DED-0856-4FF7-ACF4-2B18383F9995 Q35671234-E8B0FA99-E777-4795-BE4C-454E9DEEEE51

P2860

Nuclear factor-kappa B signaling in skeletal muscle atrophy.

http://www.wikidata.org/entity/Q34593476

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Nuclear factor-kappa B signaling in skeletal muscle atrophy.

@ast

Nuclear factor-kappa B signaling in skeletal muscle atrophy.

@en

Nuclear factor-kappa B signaling in skeletal muscle atrophy.

@nl

type

label

Nuclear factor-kappa B signaling in skeletal muscle atrophy.

@ast

Nuclear factor-kappa B signaling in skeletal muscle atrophy.

@en

Nuclear factor-kappa B signaling in skeletal muscle atrophy.

@nl

prefLabel

Nuclear factor-kappa B signaling in skeletal muscle atrophy.

@ast

Nuclear factor-kappa B signaling in skeletal muscle atrophy.

@en

Nuclear factor-kappa B signaling in skeletal muscle atrophy.

@nl

P1433

Q34593476-C6717409-1C3E-4502-A040-15A9DFD66353

P1476

Q34593476-F14EAF24-3012-4F83-9A61-F21A0F17A864

P2093

Q34593476-E5F849D5-8654-435C-9F66-C4904EC46764

Q34593476-F9309B49-44D5-4F50-94A6-E1FFE82E51DE

P2860

Q34593476-00C84C39-897B-40B0-B8E0-FB38AC012BD5

Q34593476-02E70243-84A2-4B7E-9FCD-0EB6AB5AAFE4

Q34593476-04FFA7C2-9118-42AA-9D2D-F37DBBD8C506

Q34593476-054A9C49-B20F-4164-B27B-EE639E48EDC3

Q34593476-0920D829-886D-4DD2-AF17-6A7F2EC634DF

Q34593476-12C271C1-8258-4A27-B92C-BFE295B43338

Q34593476-1382E75C-B292-4781-A08A-192827F98F13

Q34593476-15E54389-FCE4-4571-8D49-1498917E9C31

Q34593476-16903405-098B-4842-BDB6-7F89E1999BBC

Q34593476-20896FBE-3BF0-4F68-8A1B-E17C36ED8447

P2888

Q34593476-B40F008F-CC12-4650-8131-039BDD86A8A8

P304

Q34593476-9BC34D9D-EB3B-4E1D-90E7-1C2215B25065

P31

Q34593476-47D0EED1-E0A9-4AAF-ABA7-3595AC0A53B1

P356

Q34593476-E1EBB7E8-7E96-40AD-8D4B-9023E0B3E266

P433

Q34593476-B3C14DB2-A328-46EE-87D5-04C0E79BE302

P478

Q34593476-9D625BD7-FD74-420C-902A-E3329474151E

P50

Q34593476-1F6C8C72-58C5-4D96-9B47-65508854CF00

P577

Q34593476-4AB6B299-C77A-441F-93C2-30B799A92766

P5875

Q34593476-2811F839-A894-4BDA-91E7-2FF358199A61

P6179

Q34593476-5CB0749C-E9ED-4271-B140-AED0E1365963

P698

Q34593476-FB7AF9BF-537D-4D88-BE1C-CE8E1C2D3C3A

P932

Q34593476-162AFA04-2162-431E-918E-30A0E45784F1

P356

S00109-008-0373-8

P1433

Journal of Molecular Medicine

P1476

Nuclear factor-kappa B signaling in skeletal muscle atrophy

@en

P2093

Hong Li

http://www.w3.org/2001/XMLSchema#string

Shweta Malhotra

http://www.w3.org/2001/XMLSchema#string

P2860

NF-kappaB-dependent expression of the antiapoptotic factor c-FLIP is regulated by calpain 3, the protein involved in limb-girdle muscular dystrophy type 2A

Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy

Suppression of metastasis by nuclear factor kappaB inhibitors in an in vivo lung metastasis model of chemically induced hepatocellular carcinoma

NF-kappaB regulation in the immune system

Cellular and molecular regulation of muscle regeneration

Inhibition of muscle insulin-like growth factor I expression by tumor necrosis factor-alpha

Nuclear factor kappa B-inducing kinase and Ikappa B kinase-alpha signal skeletal muscle cell differentiation

Identification of ubiquitin ligases required for skeletal muscle atrophy

Shared principles in NF-kappaB signaling

Signaling to NF-kappaB

P2888

s00109-008-0373-8

P304

1113-1126

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00109-008-0373-8

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

86

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-06-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5280919

http://www.w3.org/2001/XMLSchema#string

P6179

1032068612

http://www.w3.org/2001/XMLSchema#string

P698

18574572

http://www.w3.org/2001/XMLSchema#string

P932

2597184

http://www.w3.org/2001/XMLSchema#string